Latest From Molplex Pharmaceuticals
This Month's Profile Group, BioHub At Alderley Park, features profiles of Absynth Biologics, Blueberry Therapeutics, Molplex Pharmaceuticals, and OncoTherics. Plus these Start-Ups Across Health Care: Centerline Biomedical, Laurimed, and Portal Instruments.
Molplex Pharmaceuticals’ drug discovery platform, Optiplex, uses a combination of artificial intelligence and highly automated decision-making systems in drug optimization, selecting compounds with maximum potential for efficacy combined with minimum side effects. The Optiplex database contains almost a trillion chemical structures, as well as predicted biological activities for more than a thousand human protein targets and ADME-tox properties.
Once an R&D site for AstraZeneca, the BioHub at Alderley Park is now home to a number of emerging biotechs. Profiles of Absynth Biologics, Blueberry Therapeutics, Molplex, and OncoTherics.
Drug Discovery Tools
- Drug Discovery Tools
- Therapeutic Areas
- Infectious & Viral Diseases
- Western Europe
- Parent & Subsidiaries
- Molplex Pharmaceuticals
- Senior Management
- David Leahy, PhD, CEO
- Contact Info
Phone: 1625 238713
The BioHub at Alderley Park, Mereside
Cheshire, SK10 4TG
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.